The Japanese IC device market is large but mature. Although there is modest procedural growth in PCI volumes and favorable reimbursement supporting the adoption of new technologies, strong MHLW reimbursement cuts—particularly in the PTCA balloon catheter and coronary stent segments—and the impact of the COVID-19 pandemic will negatively affect the overall market.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in Japan, with market projections across a 10-year period.

Emerging technologies such as FFRCT, resting-state FFR, and angiography-based FFR will influence the IC diagnostic landscape in Japan.

How will the adoption of FFRCT alter patient and procedure compositions in cardiac catheterization labs?

How will the emergence of alternative FFR modalities affect the FFR pressure guidewire market?

Biennial MHLW reimbursement cuts will continue to negatively affect the market values of the Japanese IC device segments.

Which markets will be most severely impacted by the MHLW reimbursement cuts?

To what degree will reimbursement cuts be compounded by market competition?

The Japan IC device market will be impacted by the COVID-19 pandemic in the early years of the forecast.

What guidance or recommendations have been issued for IC procedures in the face of infection containment and self-isolation measures?

How will the pandemic impact clinical trials and product launches?

Table of contents

  • Interventional Cardiology Devices - Market Insights - Japan

Author(s): Sangeetha Iyer, Pharm.D

Sangeetha Iyer is an analyst within the Cardiovascular Medtech Insights team at Decision Resource Group, specializing in structural heart closure and vascular access device markerts across the Asia Pacific region, as well as medical device pricing and regulations in China and Japan. Sangeetha has represnted India at the European Society of Cardiology confrerence in Greece(2016) and Sweden(2017), where her research poster was awarded the top prize. Sangeetha holds a Doctor of Pharmacy degree from the Manipal Academy of Higher Education. Follow Sangeetha on twitter: @Slyer_DRG


Related Reports

Interventional Cardiology Devices - Market Insights - United States

The US IC device market will continue to be negatively affected by policies that contribute to declining ASP

View Details

Interventional Cardiology Devices - Market Insights - Asia Pacific

Although the COVID-19 pandemic will have a negative impact on procedure volumes and market growth in 2020, the Asia Pacific

View Details

Interventional Cardiology Devices - Market Insights - Europe

The mature European IC device market will be limited by declining ASPs due to a number of factors, includ...

View Details

Interventional Cardiology Devices - Market Insights - Middle East And South Africa

The MESA IC device market will 

View Details